Down regulation of peroxisome proliferator-activated receptorγ expression by inflammatory cytokines and its reversal by thiazolidinediones

Diabetologia

Volumn 42, Issue 6, 1999, Pages 702-710

  Tanaka, T ^a   Itoh, H ^a   Doi, K ^a   Fukunaga, Y ^a   Hosoda, K ^a   Shintani, M ^a   Yamashita, J ^a   Chun, T H ^a   Inoue, M ^a   Masatsugu, K ^a   Sawada, N ^a   Saito, T ^a   Inoue, G ^a   Nishimura, H ^a   Yoshimasa, Y ^a   Nakao, K ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipocyte; Cloning; Cytokines; Glucose uptake; Insulin resistance; PPAR ; Rat; Thiazolidinediones; TNF

Indexed keywords

CYTOKINE; GLUCOSE; GLUCOSE TRANSPORTER; HYDROGEN PEROXIDE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LYSOPHOSPHATIDYLCHOLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PIOGLITAZONE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION;

ADIPOCYTES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CLONING, MOLECULAR; CYTOKINES; DEOXYGLUCOSE; DOWN-REGULATION; GLUCOSE TRANSPORTER TYPE 4; INSULIN; MALE; MOLECULAR SEQUENCE DATA; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033060675     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051218     Document Type: Article

References (39)

1. 1. Costa G (1977) Cachexia: the metabolic component of neoplastic disease. Cancer Res 37: 2327-2335
2. 2. Grunfeld C, Feingold KR (1991) Metabolic effect of tumour necrosis factor and other cytokines. Biotherapy 3: 143-158
3. 3. Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor-a: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278
4. 4. Ling PR, Bistrian BR, Mendez B, Istfan NW (1994) Effects of systemic infusions of endotoxin, tumour necrosis factor, and interleukin 1 on glucose metabolism in rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. Metabolism 43: 279-284
5. 5. Strassman G, Fong M, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin Invest 89: 1681-1684
6. 6. Metcalf D, Gearing DP (1989) Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 86: 5948-5952
7. 7. Zugmaier G, Widing G, Kanbbe C et al. (1991) Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumour effect in nude mice. Cancer Res 51: 3590-3594
8. 8. Rautonen J, Rautonen N, Martin NL, Philip R, Wara DW (1991) Serum interleukin-6 concentrations are elevated and associated with elevated tumour necrosis factor-alpha and immunogloblin G and A concentrations in children with HIV infection. AIDS 5: 1319-1325
9. 9. Miles PDG, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM (1997) TNF-α-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46: 1678-1683
10. 10. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331: 1188-1193
11. 11. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H (1988) Characterization of a new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37: 1549-1558
12. 12. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270: 12953-12956
13. 13. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM (1994) mPPARγ 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8: 1224-1234
14. 14. Nishimura H, Saltis J, Habberfield AD et al. (1991) Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol. Proc Natl Acad Sci USA 88: 11500-11504
15. 15. Ogawa Y, Itoh H, Tamura N et al. (1994) Molecular cloning of the complementary DNA and gene that overexpress the brain natriuretic peptide gene. J Clin Invest 93: 1911-1921
16. 16. Bell GI, Kayano T, Buse JB et al. (1990) Molecular biology of mammalian glucose transporters. Diabetes Care 13: 198-208
17. 17. Masuzaki H, Hosoda K, Ogawa Y et al. (1996) Augmented expression of obese (ob) gene during the process of obesity in genetically obese-hyperglycemic Wistar fatty (fa/fa) rats. FEBS Lett 378: 267-271
18. 18. Himmler A, Maurer-Fogy I, Krönke M et al. (1990) Molecular cloning and expression of human and rat tumour necrosis factor receptor chain (p60) and its soluble derivative, tumour necrosis factor-binding protein. DNA Cell Biol 9: 705-715
19. 19. Stagsted J, Reaven GM, Hansen T, Goldstein A, Olsson L (1990) Regulation of insulin receptor function by a peptide derived from a major histocompatibility complex class I antigen. Cell 62: 297-307
20. 20. Elbrecht A, Chen Y, Cullinan CA et al. (1996) Molecular cloning, expression and characterization of human peroxisome proliferator activated receptor γ1 and γ2. Biochem Biophys Res Commun 224: 431-437
21. 21. Schoonjans K, Staels B, Auwerx J (1996) The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochem Biophys Acta 1302: 93-109
22. 22. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS. (1995) Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92: 7921-7925
23. 23. Johnson PR, Greenwood MRC, Horwitz BA, Stern JS (1991) Animal models of obesity: genetic aspects. Annu Rev Nutr 11: 325-353
24. 24. Zhang B, Berger J, Hu E et al. (1996) Negative regulation of proliferator-activated receptor-γ gene expression contributes to the antiadipogenic effects of tumour necrosis factor-α. Mol Endocrinol 10: 1457-1466
25. 25. Hill MR, Young MD, Mccurdy CM, Gimble JM (1997) Decreased expression of murine PPARγ in adipose tissue during endotoxemia. Endocrinology 138: 3073-3076
26. 26. Lang CH, Dobrescu C, Bagby GJ (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43-52
27. 27. Spiegelman BM, Flier JS (1996) Adipogenesis and Obesity: Rounding out the big picture. Cell 87: 377-389
28. 28. Vidal-Puig AJ, Considine RV, Jimenez-Linan M et al. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues. J Clin Invest 99: 2416-2422
29. 29. Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care 13: 610-630
30. 30. Hunt JV, Dean RT, Wolff SP (1988) Hydroxyl radical production as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem J 256: 205-212
31. 31. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ (1991) Antioxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Colch) 81: 739-742
32. 32. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F (1993) Pharmacological doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 57: 650-656
33. 2-generating system that is activated by insulin via mechanism bypassing the receptor kinase. J Clin Invest 89: 1006-1013
34. 2 generation in human adipocyte plasma membranes is mediated by Gαi2. J Biol Chem 272: 10135-10143
35. 35. Czech MP, Lawrence JC, Lynn WS (1974) Hexose transport in isolated brown fat cells. J Biol Chem 249: 5421-5427
36. 36. Livingston JN, Gurny PA, Lockwood DH (1977) Insulin-like effects of polyamines in fat cells. J Biol Chem 252: 560-562
37. 37. Ohsumi J, Sakakibara S, Yamaguchi J et al. (1994) Troglitazone prevents the inhibitory effects of Inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135: 2279-2282
38. 38. Szalkowski D, White-Carrington S, Berger J, Zhang B (1995) Antidiabetic thiazolidinediones block the inhibitory effect of tumour necrosis factor-a on differentiation, insulin stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136: 1474-1481
39. 39. Shimaya A, Noshiro O, Hirayama R, Yoneta T, Niigata K, Sikama H (1997) Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of GLUT4 in adipose tissue of obese Zucker rats. Euro J Endocrinol 137: 693-700